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Abstract
Background:  Vitamin D plays a critical role in bone metabolism and many cellular and
immunological processes. Recent research indicates that concentrations of serum 25-
hydroxyvitamin D [25(OH)D], the main indicator of vitamin D status, should be in excess of 75
nmol/L. Low levels of 25(OH)D have been associated with several chronic and infectious diseases.
Previous studies have reported that many otherwise healthy adults of European ancestry living in
Canada have low vitamin D concentrations during the wintertime. However, those of non-
European ancestry are at a higher risk of having low vitamin D levels. The main goal of this study
was to examine the vitamin D status and vitamin D intake of young Canadian adults of diverse
ancestry during the winter months.
Methods: One hundred and seven (107) healthy young adults self-reporting their ancestry were
recruited for this study. Each participant was tested for serum 25(OH)D concentrations and
related biochemistry, skin pigmentation indices and basic anthropometric measures. A seven-day
food diary was used to assess their vitamin D intake. An ANOVA was used to test for significant
differences in the variables among groups of different ancestry. Linear regression was employed to
assess the impact of relevant variables on serum 25(OH)D concentrations.
Results: More than 93% of the total sample had concentrations below 75 nmol/L. Almost three-
quarters of the subjects had concentrations below 50 nmol/L. There were significant differences in
serum 25(OH)D levels (p < 0.001) and vitamin D intake (p = 0.034) between population groups.
Only the European group had a mean vitamin D intake exceeding the current Recommended
Adequate Intake (RAI = 200 IU/day). Total vitamin D intake (from diet and supplements) was
significantly associated with 25(OH)D levels (p < 0.001). Skin pigmentation, assessed by measuring
skin melanin content, showed an inverse relationship with serum 25(OH)D (p = 0.033).
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Conclusion: We observe that low vitamin D levels are more prevalent in our sample of young
healthy adults than previously reported, particularly amongst those of non-European ancestry.
Major factors influencing 25(OH)D levels were vitamin D intake and skin pigmentation. These data
suggest a need to increase vitamin D intake either through improved fortification and/or
supplementation.
Background
Vitamin D plays a critical role in bone metabolism and
many cellular and immunological processes [1-4]. Low
levels of vitamin D have been associated with various
chronic and infectious diseases including cancer, multiple
sclerosis, diabetes, rheumatoid arthritis, osteoporosis, car-
diovascular disease, and microbial infections [5-13]. Vita-
min D is synthesized in the skin upon exposure to the
sun's ultraviolet B radiation (UVB) [12]. Vitamin D can
also be acquired from the diet from sources where it
occurs naturally (such as fatty fish, fish oil and eggs), from
fortified products (such as milk and orange juice) and
from supplements [12]. For many people, exposure of
their skin to UVB is the primary source of their vitamin D
[4,14]. However, at latitudes far from the equator, such as
Canada, the amount of UVB available from sunlight dur-
ing the winter months is inadequate to allow cutaneous
vitamin D synthesis [4,15].
Several other factors can affect vitamin D concentrations,
including: skin pigmentation (melanin, the major natural
pigment in the skin, interferes with cutaneous production
of vitamin D) [16,17]; age (the skin loses the ability to
synthesize vitamin D with increased age) [14,18]; weight
(higher adiposity has been associated with lower vitamin
D levels) [19-22]; deliberate avoidance of sun exposure
and/or use of sunblock (due to sun safety or cultural rea-
sons) [12,23]; malabsorption disorders which affect the
body's ability to absorb vitamin D (including celiac dis-
ease, Crohn's disease, cystic fibrosis) [24]; diseases and
disorders of the kidneys and/or liver that affect vitamin D
metabolism [12] and use of certain medications (includ-
ing anticonvulsants, anti-rejection medications, corticos-
teroids) [12,25].
The standard method for the determination of vitamin D
status tests the circulating concentration of serum 25-
hydroxyvitamin D [25(OH)D], which measures the
amount of vitamin D coming into the body from all
sources (cutaneous synthesis, diet or supplements) [26].
Previous efforts to assess optimal serum 25(OH)D levels
focused on the role of vitamin D in bone health, and the
optimal 25(OH)D concentration was defined as the con-
centration that maximally suppressed serum parathyroid
hormone (PTH) and promoted maximum calcium
absorption [27]. In general, vitamin D "deficiency" was
classified as concentrations below 25–27.5 nmol/L
[28,29]. Levels below these cutoffs are associated with cal-
cium malabsorption, severe hyperparathyroidism and
vitamin D rickets or osteomalacia [30]. Some past studies
have considered serum 25(OH)D levels of 40–50 nmol/L
as the low end of the normal range [31,32]. However,
other studies have shown that PTH levels [33,34] and cal-
cium absorption [35] are not optimized until serum
25(OH)D levels reach approximately 80 nmol/L. Most
vitamin D researchers now recognize that concentrations
of serum 25(OH)D should be in excess of 75 nmol/L for
multiple health outcomes, not only bone health [27,36].
Accordingly, recent reports refer to serum 25(OH)D levels
> 75 nmol/L as "optimal", between 75 nmol/L and 50
nmol/L as "insufficient" and < 50 nmol/L as "deficient"
[37]. In our study, we report the percentage of the individ-
uals in our sample under three widely used cutoffs, 25
nmol/L, 50 nmol/L and 75 nmol/L, and we consider
25(OH)D levels > 75 nmol/L as optimal.
Previous research indicates that vitamin D concentrations
are low in many otherwise healthy Canadian adults, par-
ticularly during the winter months [28,38]. Vieth et al.
[28] studied a sample of young women (18–35 years old)
in Toronto and found that 21% of white women, 31.9%
of non-white women (a group which combined women
of First Nations, South Asian, Indo-Asian and East Asian
ancestries) and 25% of black women had serum concen-
trations below 40 nmol/L during the winter months.
Rucker et al. [38] examined a group of men and women of
mostly European ancestry living in western Canada and
observed that 20% had serum concentrations below 40
nmol/L, 39% had serum concentrations below 50 nmol/
L and 86% had serum concentrations below 80 nmol/L.
Past studies examining the vitamin D status of Canadians
have focused primarily on individuals of European ances-
try and have included few or no individuals of other
ancestries, who constitute a large proportion of the popu-
lation of Canadian metropolitan areas [39]. Individuals of
European ancestry have a lower risk of vitamin D insuffi-
ciency because they have low cutaneous melanin levels. It
is well known that melanin interferes with the production
of vitamin D in the skin and that individuals with darker
skin pigmentation are at increased risk of vitamin D insuf-
ficiency [40]. Therefore, it is likely that the prevalence of
insufficiency among all Canadians exceeds currently
reported estimates [28,38]. Additionally, previous studiesBMC Public Health 2008, 8:336 http://www.biomedcentral.com/1471-2458/8/336
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in Canada have failed to measure pigmentation quantita-
tively. Therefore, it is critical to expand the existing
research to explore how differences in skin pigmentation
[41] or other factors potentially associated with vitamin D
levels, such as vitamin D dietary intake, supplementation
or sun exposure, affect the vitamin D status of broadly
defined population groups. Results of such studies will be
important to inform public health policies regarding for-
tification and recommendation of intakes in order to
ensure that all Canadians have sufficient vitamin D levels.
The aim of this study is to evaluate the wintertime vitamin
D status and dietary vitamin D intake of young adults of
diverse ancestry in Canada, and to assess the impact of
quantitatively measured skin pigmentation and dietary
intake on serum 25(OH)D levels.
Methods
Study Population and Recruitment
Study recruitment took place at the University of Toronto
at Mississauga (Ontario, Canada) during the winter of
2007. The study was advertised to the University of
Toronto community online, and also via the use of adver-
tisements at the University of Toronto at Mississauga cam-
pus. Most of the participants were either students or
employees of the university.
Participant eligibility for the study was assessed using a
questionnaire that was completed prior to study enroll-
ment. The following were exclusion criteria: age (only par-
ticipants between the ages of 18 and 30 were recruited for
this study), diagnosis of kidney/liver damage or other dis-
orders or diseases that may affect vitamin D metabolism
or absorption (including osteomalacia, osteopenia,
Crohn's disease, etc.), use of medications that affect vita-
min D metabolism (steroids, anticonvulsants, etc.) and
recent exposure to UVB (such as visits to tanning salons or
trips to sunny destinations less than three months before
recruitment). Use of vitamin D supplements was not an
exclusionary variable because we were interested in evalu-
ating how many participants take vitamin D supplements,
and the effect of supplementation on 25(OH)D levels.
Participant ancestry was assessed based on responses to a
personal questionnaire, which asked questions pertaining
to the birthplace, migration history, native languages and
self-reported ethnicity of the participants, their parents
and grandparents.
In total, one hundred and seven subjects (58 females, 49
males) were eligible and agreed to participate. This study
was approved by the University of Toronto Health Sci-
ences Research Ethics Board, and all participants provided
written informed consent.
Data Collection
Participants met with the researchers twice during the
study. During the initial visit, which took place between
February 14 and March 16, the participants completed a
personal questionnaire that assessed ancestry (personal,
parental, and grandparental places of birth, ethnicity, lan-
guage, migration history, and present residence). Anthro-
pometric measurements (weight and height) were also
taken, from which body mass index (BMI) was calculated
for each participant. All participants were instructed to
complete a 7-day food diary, which recorded all beverages
and food items consumed over a 7-day period, and a
blood sample was drawn. During the second visit, which
in most cases took place within two weeks of the first visit,
participants returned the completed food diaries and were
reimbursed for their participation.
Measuring Pigmentation using Reflectometry
Melanin content was measured in the inner upper arm
using a narrow band reflectometer during the initial visit
(Dermaspectrometer, Cortex Technology, Hadsund, Den-
mark) [42]. Measurements taken on the upper inner arm
represent constitutive skin pigmentation (pigmentation
in unexposed areas of the skin). The Dermaspectrometer
estimates the amount of melanin in the skin from the
amount of light reflected back to the machine in the red
and green wavelengths of the light spectrum [42]. Skin
color is primarily influenced by two pigments: hemo-
globin and melanin, with hemoglobin showing a large
optical absorption peak in the green wavelengths and a
sharp drop off in the red wavelengths (this is why blood
appears red), while melanin shows absorption of light at
all wavelengths [42]. Based on the differences in the spec-
tral curves of the two pigments, Diffey et al. [43] suggested
that the reflectance of light in the red spectrum would gen-
erate an estimate of the melanin content of human skin,
following the equation, Melanin = log10 (1% red reflect-
ance). Melanin Index values calculated using the Der-
maspectrometer range from the low 20s to more than
100, with individuals with the lightest skin pigmentation
having the lowest values and those with the darkest pig-
mentation having the highest [42].
Biochemical Analyses
An aliquot of whole blood was centrifuged and the serum
fraction was removed after clotting and stored at -80°C.
Serum parathyroid hormone (PTH), calcium, phosphate,
and creatinine, were measured on the automated Modular
Analytics Serum Work Area (Roche, Basel, Switzerland).
Serum 25-hydroxyvitamin D [25(OH)D] concentrations
were determined by the DiaSorin "25-OH Vitamin D
TOTAL" competitive chemiluminescence immunoassay
on the automated LIAISON® analyzer (Stillwater, MN).
This method has 100% specificity for both 25(OH) vita-BMC Public Health 2008, 8:336 http://www.biomedcentral.com/1471-2458/8/336
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min D2 and 25(OH) vitamin D3. This assay has a limit of
detection of 10 nmol/L, an intra-assay coefficient of vari-
ation (CV) of 5%, and an inter-assay CV of 7%. Samples
were analyzed in one continuous batch with quality con-
trol samples inserted at periodic intervals.
This 25(OH)D "total" method was previously validated
with a different sample set in which serum 25(OH)D was
measured using both the "total" method and the DiaSorin
radioimmunoassay (RIA) (DiaSorin, Stillwater, MN). A
comparison showed a strong correlation between the
methods (r2 = 0.814). Statistically, serum 25(OH)D con-
centrations determined by both methods were indistin-
guishable from one another (p = 0.17, paired t-test).
Nutritional Analyses
Daily intake of vitamin D from dietary and supplemental
sources was estimated using a 7-day food diary. Subjects
were provided with portion size aids and recorded their
food, beverage and supplement intake for seven consecu-
tive days. Vitamin D intake was analyzed with the compu-
ter program Food Processor (version 8.0 and its revisions,
ESHA Research Inc., Salem OR, which included the 1997
Canadian Nutrient File from Health Canada); Canadian
foods were always chosen where fortification was differ-
ent from USA, e.g., margarine, breakfast cereals.
Statistical Analyses
Differences between population groups in serum
25(OH)D levels and vitamin D intake were evaluated
using ANOVA. For these analyses, serum 25(OH)D was
log transformed and vitamin D intake was transformed
using the square-root transformation. The effects of age,
sex, BMI, total vitamin D intake and skin pigmentation
(melanin content) on log serum 25(OH)D levels were
explored using multiple linear regression. All statistical
tests were performed with SPSS (Version 15.0, SPSS Inc.,
2006). A power analysis using the software G*Power (Ver-
sion 3) [44] indicated that, using a significance level of α
= 0.05, our study has approximately 87% power to detect
a large effect size (f = 0.40) in an ANOVA analysis (with a
sample size of 75 individuals in three groups) and approx-
imately 87% power to detect a medium effect size (f2 =
0.15) in a multiple regression analysis (with a sample size
of 107 individuals with five predictors).
Results
Sample Characteristics
Participants were divided into broadly defined subsets
based on self-reported geographic origin gathered in the
personal questionnaire. Most of the participants self-iden-
tified as being of either African, East Asian, European or
South Asian ancestry. Individuals who reported being of
other ancestries or of multiple ancestries were placed into
another subgroup designated as "Other". Table 1 summa-
rizes the clinical and biochemical characteristics for the
total sample and the three population groups well repre-
sented in the sample (East Asian, European and South
Asian). Because of the small sample size of individuals in
the African and "Other" subgroups, these subgroups were
not included in the statistical analyses. The following var-
iables showed significant differences between the sexes:
age (mean male = 21.5, female mean = 20.1 p = 0.002),
BMI (male mean = 21.2 female mean = 18.7, p = 0.002),
creatinine (male mean = 81.4, female mean = 59.4, p <
0.001) and calcium (male mean = 2.43, female mean =
2.38, p = 0.003). An ANOVA showed that, after control-
ling for age and sex, there were no significant differences
in PTH, calcium, phosphate, and creatinine concentra-
tions between the three ancestral groups (European, East
Asian and South Asian). However, there were significant
differences in serum 25(OH)D concentrations among the
three groups (see below). The mean melanin index for the
total sample was 33.0, and ranged from 22.4–53.5. Mean
melanin index values (and ranges) for the different groups
were as follows: East Asian = 32.0 (range 26.7–40.4);
European = 28.6 (range 22.4–32.3); and South Asian =
38.3 (range 29.8–53.5). An ANOVA showed that that
there was a significant difference in pigmentation among
the groups, even after controlling for sex and age.
Table 1: Description of the variables collected in the global sample, and stratified by ancestry.
Total Sample* East Asian European South Asian
N (Females, Males) 107 (57, 50) 27 (17, 10) 32 (16, 16) 32 (19, 13)
Age 21 (18, 25) 21 (18, 24) 21 (18, 26) 21 (18, 25)
BMI 19.9 (15.0, 26.6) 18.6 (14.9, 27.4) 20.7 (16.5,28.0) 19.9 (14.4, 25.8)
Melanin Index 35.1 (26.3, 52.7) 32.0 (27.5, 36.8) 28.6 (25.2, 32.0) 38.3 (31.8, 46.8)
25(OH)D (nmol/L) 39.4 (15.3, 77.1) 34.5 (15.1, 71.5) 55.9 (26.7, 96.3) 30.5 (13.3, 51.6)#
PTH (pmol/L) 3.4 (1.8, 5.4) 3.1 (1.9, 4.7) 3.1 (1.8, 5.2) 3.5 (1.7, 5.3)
Calcium (nmol/L) 2.4 (2.3, 2.5) 2.4 (2.2, 2.6) 2.4 (2.3, 2.5) 2.4 (2.3, 2.5)
Phosphate (nmol/L) 1.1 (0.8, 1.3) 1.1 (0.9, 1.3) 1.1 (0.8, 1.3) 1.1 (0.8, 1.4)
Creatinine (μmol/L) 69.4 (48.0, 92.7) 66.5 (45.2, 92.7) 72.9 (56.6, 90.9) 66.8 (48.0, 91.0)
Mean values and 5th and 95th percentiles (in parentheses) are reported.*Total sample comprises individuals of African ancestry (n = 7), East Asian 
ancestry (n = 27), European ancestry (n = 32), Other ancestry (n = 9), and South Asian ancestry (n = 32). #25(OH)D measurements were not 
available for one individual of South Asian ancestry, hence n = 106 for this variable.BMC Public Health 2008, 8:336 http://www.biomedcentral.com/1471-2458/8/336
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Vitamin D Status and Ancestry
Figure 1 shows the distribution of serum 25(OH)D con-
centrations according to ancestry. Only one individual
had serum measurements below the 10 nmol/L limit of
detection. Table 2 reports vitamin D status for all partici-
pants, and stratified according to ancestry using three
widely used cutoffs: < 25 nmol/L, < 50 nmol/L, < 75
nmol/L and finally, optimal vitamin D levels (≥ 75 nmol/
L).
The mean serum 25(OH)D concentration in the global
sample was 39.4 ± 21 nmol/L (range: 10–111 nmol/L).
The mean was highest in Europeans (55.9, range 16.4–
110.0 nmol/L), followed by East Asians (34.5, range
10.9–111.0 nmol/L) and lowest in South Asians (30.5,
range 10–57.8 nmol/L). Only 6.6% of the total sample
had optimal 25(OH)D concentrations, defined as > 75
nmol/L. Almost three-quarters (74%) of the sample had
concentrations below 50 nmol/L. More importantly,
25(OH)D levels showed substantial variation according
to ancestry: 34.4% of the subjects of European ancestry
had concentrations < 50 nmol/L, while 85.2% of East
Asians and 93.5% of South Asians had 25(OH)D levels <
50 nmol/L (Fisher's exact test, p < 0.001).
Analysis of the ancestry-specific group means for log
serum 25(OH)D concentrations by ANOVA showed sig-
nificant differences for the European, East Asian and
South Asian samples (p < 0.001). Post-hoc tests (Tukey
HSD) revealed that these results were driven by the signif-
icantly higher serum 25(OH)D concentrations in the
European group with respect to the other two groups: East
Asian and European (p < 0.001), and South Asian and
European (p < 0.001). No significant pairwise differences
in mean serum 25(OH)D were found between East Asians
and South Asians (p = 0.775).
Vitamin D Intake and Ancestry
Mean vitamin D intake in the total sample and stratified
by ancestry is reported in Table 3. Mean daily total vita-
min D intake was substantially higher in the European
sample (231.0 ± 173.5 International Units-IU) than in the
East Asian (133.4 ± 101.7 IU) and South Asian (164.3 ±
144.3 IU) samples. In all groups, mean daily dietary
intake of vitamin D was greater than mean daily intake
from supplements. Only 22.9% of the participants
reported the use of supplements. Vitamin D intake from
food sources was highest in the European group as was
vitamin D intake from supplements.
Total daily vitamin D intake (from diet and supplements,
transformed using the square-root transformation) dif-
fered significantly among groups (ANOVA for East Asian,
European and South Asian samples; p = 0.034). No signif-
icant differences in vitamin D intake were observed
between the sexes.
The current recommendation for Adequate Intake (AI) of
vitamin D is 200 IU/day for individuals between the ages
of 19–50 [29]. The availability of vitamin D intake data in
our study allowed us to further evaluate 25(OH)D levels
in individuals with a vitamin D daily intake higher than
200 IU. When the sample was stratified according to total
vitamin D intake and we analyzed only the 25(OH)D lev-
els of the individuals with intakes higher than 200 IU/day,
84.4% of the individuals had serum 25(OH)D concentra-
tions < 75 nmol/L and 40.6% of the individuals showed
25(OH)D levels < 50 nmol/L.
Factors Affecting Vitamin D Status
Several variables are known to affect vitamin D status and
these were assessed for their influence on serum
25(OH)D: age [14,18], BMI [19-22], vitamin D intake
[37,45] and constitutive skin pigmentation [16,17,46]. A
linear regression analysis was performed with log serum
as the dependent variable and age, sex, BMI, total vitamin
D intake and skin pigmentation as the independent varia-
bles. The regression analysis revealed that almost 35% of
the variation in log serum 25(OH)D concentrations was
explained by the linear combination of the variables
tested (r2 = 0.339, F(5,98) = 10.049, p < 0.001). Table 4
shows the bivariate and partial correlations for each of the
variables tested in the model. Only two of the five tested
variables had a statistically significant relationship with
serum 25(OH)D concentrations: total vitamin D intake (p
< 0.001) and skin pigmentation (p = 0.033). On the basis
of this analysis, we can infer that both total vitamin D
intake and constitutive skin pigmentation are predictors
of serum 25(OH)D in this sample. Total vitamin D intake
showed a positive correlation with total vitamin D intake
Table 2: Wintertime vitamin D status in the global sample, and stratified by ancestry
Vitamin D Status Total Sample* (n = 106) East Asian (n = 27) European (n = 32) South Asian (n = 31)
% < 25 nmol/L 25.5 29.6 6.2 35.5
% < 50 nmol/L 73.6 85.2 34.4 93.5
% < 75 nmol/L 93.4 92.6 84.4 100.0
% > 75 nmol/L 6.6 7.4 15.6 0.0
*Total sample comprises individuals of African ancestry (n = 7), East Asian ancestry (n = 27), European ancestry (n = 32), Other ancestry (n = 9), 
and South Asian ancestry (n = 31). 25(OH)D measurements were not available for one individual of South Asian ancestry.BMC Public Health 2008, 8:336 http://www.biomedcentral.com/1471-2458/8/336
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and it alone explained 30.4% of the variance in serum
25(OH)D concentrations. Controlling for all the other
variables in the analysis (age, BMI, sex and total vitamin
D intake), total vitamin D intake explained 28.9% of the
variance in serum 25(OH)D (see partial correlations in
Table 4). Constitutive skin pigmentation shows a negative
correlation with serum 25(OH)D and explained 6.5% of
the variation in serum 25(OH)D. When controlling for all
the other variables, skin pigmentation explained 4.5% of
the variance in serum 25(OH)D.
Examination of the partial regression plots suggested the
presence of an outlier and the dataset was checked for out-
liers by examining casewise diagnostics, leverage statistic
(h) and Mahalanobis distance. The following criteria were
used: casewise diagnostics set at > 3 standard deviations,
h > 0.2 and Mahalanobis distance > 20.52 (χ2 = 20.52,
with df = 5 and α = 0.001). One outlier was identified by
both leverage statistics and Mahalanobis distance. This
case was investigated and it was observed that this partic-
ipants' pigmentation was the darkest in the sample (Mel-
anin Index was 15 points higher than the second darkest
person). The outlier was removed and the regression was
performed again with no report of other outliers.
With the removal of the outlier, the strength of the multi-
ple regression model improved (r2  = 0.374, F(5,97)  =
11.597, p < 0.001). Once again, only total vitamin D
intake (p < 0.001) and skin pigmentation (p = 0.003) had
a significant effect on serum 25(OH)D concentrations.
With the removal of the outlier, total vitamin D intake
explained 30.9% of the variation in serum 25(OH)D. The
relationship between serum 25(OH)D and skin pigmen-
tation also increased with the removal of the outlier and
skin pigmentation accounted for 9.2% of the variation in
serum 25(OH)D (compared to 6.5% when the outlier was
present in the dataset).
Discussion
Our findings indicate that vitamin D levels are very low in
a cohort of healthy young adults living in Southern
Ontario, particularly among those of non-European
ancestry. Two previous studies examined vitamin D status
in the Canadian population, but both primarily sampled
individuals of European ancestry [28,38]. Our study is
consistent with Rucker et al. [38] in that most individuals
had serum concentrations below the levels considered
optimal by most vitamin D experts (86% had serum
25(OH)D concentrations below 80 nmol/L in Rucker et
al. compared to 93% of all participants in our study hav-
ing serum 25(OH)D < 75 nmol/L). However, a key find-
ing of our study is that there were significant differences in
vitamin D levels among broadly defined ancestral groups
living in Canada. Two previous Canadian studies defined
vitamin D insufficiency as serum 25(OH)D levels < 40
nmol/L, and in these studies 21% and 20% of individuals
of European ancestry had concentrations lower than this
cutoff [28,38]. In our sample, 22% of individuals of Euro-
pean ancestry had 25(OH)D levels less than the 40 nmol/
Boxplot showing serum 25(OH)D concentrations by ances- try Figure 1
Boxplot showing serum 25(OH)D concentrations by 
ancestry. The boxplot presents five statistics: the top of the 
box represents the 75th percentile, the line within the box 
represents the median and the bottom of the box represents 
the 25th percentile, while the whiskers correspond to the 
minimum and maximum values that are not outliers. The 
points above or below the whiskers represent outliers. The 
asterisk (*) on the plot corresponds to an outlier whose 
serum levels were the highest reported in this study (110 
nmol/L).
Table 3: Mean dietary, supplemental and total vitamin D intake (reported as International Units, IU, per day) in the global sample, and 
stratified by ancestry.
Sources (IU/day) Total Sample (n = 105) East Asian (n = 27)E u r o p e a n  ( n = 31)S o u t h  A s i a n  ( n = 32)
Dietary 121.0 (17.1, 309.5) 96.6 (6.71, 213.1) 141.6 (29.1, 321.4) 129.9 (21.9, 355.3)
Supplemental 50.7 (0, 388.5) 36.8 (0, 171.43) 89.4 (0, 400) 34.4 (0, 214.1)
Total 171.7 (19.7, 464.3) 133.4 (8.0, 311.5) 231.0 (34.03, 582.67) 164.3 (27.7, 391.7)
The 5th and 95th percentiles are indicated in parentheses. *Total sample comprises individuals of African ancestry (n = 7), East Asian ancestry (n = 
27), European ancestry (n = 31), Other ancestry (n = 8), and South Asian ancestry (n = 32). Vitamin D intake data were not available for one 
individual of European ancestry and one individual of Other ancestry.BMC Public Health 2008, 8:336 http://www.biomedcentral.com/1471-2458/8/336
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L cutoff, which is comparable to the values observed in
previous studies [28,38]. However, in our study, 78% of
individuals of East Asian ancestry and 77% of individuals
of South Asian ancestry had 25(OH)D concentrations
lower than 40 nmol/L. These findings demonstrate that
while low concentrations of vitamin D were common dur-
ing wintertime in young adults living in Canada, those of
East Asian and South Asian ancestry had vitamin D con-
centrations that were much lower than their European
counterparts.
In our sample, wintertime vitamin D status appears to be
affected by both total vitamin D intake and skin pigmen-
tation. The observation that wintertime 25(OH)D levels
were primarily influenced by total vitamin D intake is not
surprising, given that there is insufficient UVB for cutane-
ous vitamin D synthesis during the winter months in Can-
ada [15]. Our finding that there was a significant inverse
relationship between skin pigmentation and wintertime
serum 25(OH)D concentrations seems to suggest that,
when there is sufficient UVB for vitamin D synthesis (late
spring, summer and early fall), melanin interferes with
the production of vitamin D and this differential cutane-
ous production of vitamin D is reflected in wintertime
25(OH)D levels [46-48]. Our results are consistent with
those of a recently published study [46] which showed
that skin pigmentation (measured quantitatively using a
reflectometer) had a significant effect on both basal
25(OH)D levels and the rates of increase of 25(OH)D
after UVB exposure. Although other studies have noticed
the effects of age [18] and obesity [22,49] on serum
25(OH)D, these relationships were not observed in our
study, likely because our participants were exclusively
young adults (18–30 years) who showed more limited
variation in BMI and WHR (Table 1) than earlier studies
[18,20,21,49].
Little is known about the vitamin D intake of non-First
Nations Canadians who self-report non-European ances-
try [50]. Our results indicate that the mean total vitamin
D intake from food and supplements in individuals of
East Asian and South Asian ancestry was lower than the
current Health Canada recommendation for young adults
of 200 IU/day [29]. Our study suggests that those at great-
est risk of vitamin D insufficiency are consuming the low-
est amounts of vitamin D in their diet and/or
supplemental sources. Even consuming the amount of
vitamin D currently recommended by Health Canada
does not prevent vitamin D insufficiency during the win-
ter in samples consisting primarily of Canadians of Euro-
pean-ancestry [28].
Our study has a number of limitations. The sample was
primarily comprised of young adults recruited at the Uni-
versity of Toronto, and may not reflect the general popu-
lation of young people in Canada. Additionally, we did
not explore the seasonal variation in vitamin D levels. The
sample only featured three well represented population
groups, and obviously does not encompass the great pop-
ulation diversity found in Canada, and more particularly,
in Canadian metropolitan areas [39]. However, it should
be noted that our sample better represented the popula-
tion diversity of the Greater Toronto Area than previous
studies. The 2006 Canadian census found that visible
minorities represent 42.9% of the population of Toronto
and 49% of the population of Mississauga [39]. Individu-
als of South Asian, Chinese and African Canadian ancestry
make up the three largest visible minorities of the Toronto
area and represent 31% of all the visible minorities in the
city of Toronto. In the city of Mississauga, 41% of all visi-
ble minorities are of South Asian ancestry [39]. We are
currently working on a study that will examine the sea-
sonal variation in vitamin D status in a much larger sam-
ple that will better reflect the diverse demographic
makeup of Canada.
Conclusion
Our study suggests that the prevalence of low vitamin D
levels in young adults living in Canada (Southern
Ontario) may be higher than previously described. Our
sample included individuals of diverse ancestry, and as
such provides a better representation of the multi-ethnic
composition of Canadian metropolitan areas than previ-
ous studies. Our research also indicates that there are dif-
ferences in serum 25(OH)D levels and vitamin D intake
between population groups and that the currently Recom-
mended Adequate Intake of vitamin D (RAI = 200 IU/day)
may not be met by a large proportion of the young adults.
Vitamin D intake was particularly low amongst those
young Canadians at greatest risk of vitamin D insuffi-
ciency. Furthermore, our study suggests that the current
vitamin D recommendations in the US and Canada (200
IU/day) are insufficient to ensure optimal circulating
Table 4: Bivariate and partial correlations between serum 
25(OH)D and five relevant variables.
Predictor Correlations p
Bivariate* Partial#
Age 0.024 0.081 0.425
BMI -0.051 0.000 0.997
Sex -0.080 0.003 0.977
Skin Pigmentation -0.254 -0.213 0.033
Total Vitamin D Intake 0.551 0.538 < 0.001
*Bivariate correlations represent the correlation between serum 
25(OH)D and each variable. #Partial correlations represent the 
correlation between serum 25(OH)D and each variable, controlling 
for all other variables.BMC Public Health 2008, 8:336 http://www.biomedcentral.com/1471-2458/8/336
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25(OH)D levels, which are defined by most vitamin D
experts as 75 nmol/L [27,36].
The Canadian Cancer Society has recently recommended
that a vitamin D supplement of 1000 IU/day be taken by
all Canadian adults during the fall and winter, and that
those at increased risk should consider year round supple-
mentation [51]. Other Canadian organizations have also
recommended higher intakes (800–2000 IU) for adults
[51-53]. Although further research is needed to determine
the vitamin D requirements of individuals of diverse
ancestry living in Canada, the results of our study support
the need for higher vitamin D intakes to improve the over-
all health of young Canadians, and the need for food for-
tification strategies to meet these requirements.
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